Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Active Not Recruiting1
Not Yet Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06162715Phase 2Active Not Recruiting

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

NCT07695454Not Yet Recruiting

Imaging in Semaglutide Study

NCT03755323UnknownPrimary

Establishment of a Database of Patients Suffering From Obesity With a Medical Treatment

Showing all 3 trials

Research Network

Activity Timeline